Literature DB >> 33686684

Bacterial Growth Inhibition Screen (BGIS) identifies a loss-of-function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin.

Haihong Guo1, Malte Prell1, Hiltrud Königs2, Nengwei Xu3, Tanja Waldmann4, Benita Hermans-Sachweh2, Elisa Ferrando-May5, Bernhard Lüscher1, Ferdinand Kappes1,3.   

Abstract

The DEK oncoprotein regulates cellular chromatin function via a number of protein-protein interactions. However, the biological relevance of its unique pseudo-SAP/SAP-box domain, which transmits DNA modulating activities in vitro, remains largely speculative. As hypothesis-driven mutations failed to yield DNA-binding null (DBN) mutants, we combined random mutagenesis with the Bacterial Growth Inhibition Screen (BGIS) to overcome this bottleneck. Re-expression of a DEK-DBN mutant in newly established human DEK knockout cells failed to reduce the increase in nuclear size as compared to wild type, indicating roles for DEK-DNA interactions in cellular chromatin organization. Our results extend the functional roles of DEK in metazoan chromatin and highlight the predictive ability of recombinant protein toxicity in E. coli for unbiased studies of eukaryotic DNA modulating protein domains.
© 2021 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990Escherichia colizzm321990; DEK; SAP domain; chromatin; oncogene; protein domain; protein function; recombinant protein toxicity

Year:  2021        PMID: 33686684     DOI: 10.1002/1873-3468.14070

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  1 in total

1.  Inhibition of DEK Enhances Doxorubicin-Induced Apoptosis and Cell Cycle Arrest in T-Cell Acute Lymphoblastic Leukemia Cells.

Authors:  Xiaoxue Tian; Zeyu Zhu; Guangming Wang; Jun Xu; Aibin Liang; Wenjun Zhang
Journal:  Dis Markers       Date:  2022-06-20       Impact factor: 3.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.